The Democratic Republic of Congo (DRC) and its neighbor Uganda are grappling with a severe outbreak of Bundibugyo Virus Disease (BVD), a form of Ebola. On May 15, 2026, both nations independently confirmed the emergence of this deadly illness. Swiftly thereafter, on May 16, 2026, the World Health Organization (WHO) Director-General escalated the alarm, declaring the BVD situation in the DRC and Uganda a Public Health Emergency of International Concern (PHEIC). This declaration signals a grave global health risk, demanding coordinated international response and heightened vigilance from all countries. ## Understanding Bundibugyo Virus Disease (BVD) Bundibugyo Virus Disease (BVD) is one of the types of Ebola disease, caused by the Bundibugyo virus, a member of the *Orthoebolavirus* family. This illness is zoonotic, meaning it typically spreads from animals to humans, with fruit bats widely suspected as the natural carriers of the virus. Human infection usually occurs through direct contact with the blood, secretions, organs, or other bodily fluids of infected animals. Once the virus enters the human population, it can spread rapidly from person to person through similar direct contact with an infected individual's bodily fluids or contaminated surfaces and objects. Historically, BVD outbreaks have shown case fatality rates ranging from 30% to 50%, making it a highly lethal disease. After an incubation period that can range from 2 to 21 days, initial symptoms of BVD are often non-specific, resembling common illnesses like malaria or influenza. Patients may experience fever, fatigue, muscle pain, headache, and a sore throat. As the disease progresses, it can lead to severe gastrointestinal issues, organ failure, and in some cases, internal and external bleeding. This initial ambiguity in symptoms makes early diagnosis challenging, frequently delaying detection and enabling further spread within communities and healthcare settings, especially if infection prevention and control (IPC) measures are not rigorously followed. Crucially, unlike some other Ebola strains, there are currently no licensed vaccines or specific antiviral treatments for BVD, making supportive care, rapid detection, and robust public health measures the cornerstones of control. ## The Outbreak's Epicenter: Democratic Republic of Congo As of May 21, 2026, the Democratic Republic of Congo has reported a significant number of cases. The Ministry of Public Health, Hygiene and Social Welfare confirmed the outbreak after laboratory verification of BVD in multiple samples. A total of 746 suspected cases, tragically including 176 deaths, have been reported across 15 health zones within Ituri, North Kivu, and South Kivu provinces. Among these, 83 confirmed cases have been identified, resulting in nine deaths. Four healthcare worker deaths have also been reported, highlighting the extreme risks faced by frontline staff and potential gaps in safety protocols. Transmission appears concentrated in key health zones like Mongbwalu, Rwampara, and Bunia, which collectively account for a vast majority of both suspected and confirmed cases. Mongbwalu, being a bustling mining area, is thought to be the origin point, with cases subsequently spreading as individuals sought medical care in other towns. The response efforts in the DRC are severely hampered by ongoing conflict in Ituri province, restricting movement for surveillance teams, hindering the deployment of rapid response teams, and making the secure transport of laboratory samples incredibly difficult. Insecurity also means that tracking individuals who have been in contact with infected people is often weak, with a follow-up rate as low as 21%. Furthermore, challenges include a lack of standardized isolation and treatment facilities, inconsistent implementation of safe burial practices, and pervasive misinformation that can undermine public health initiatives. An American national, a surgeon working in the DRC, was also confirmed positive and has been transferred to Germany for specialized treatment, underscoring the international implications of the outbreak. ## Uganda's Vigilance: Imported Cases Under Scrutiny Uganda also confirmed its first BVD cases on May 15, 2026. As of May 20, the country has reported two confirmed imported cases, both identified in the capital, Kampala. Sadly, one of these imported cases resulted in a death. Neither case has shown an apparent link to each other, indicating separate importations. Importantly, at the time of reporting, Uganda has not yet identified any local transmission within its borders, suggesting prompt action has prevented wider community spread. Ugandan health authorities, in collaboration with the WHO and partners, have been swift in their response. They have identified and are actively monitoring 127 contacts linked to the imported cases, including close household members and healthcare workers who provided care. Border surveillance has been significantly strengthened at both official and informal crossings, as well as along major transit routes, especially given the proximity to DRC's affected areas. The activation of the National Public Health Emergency Operations Centre (EOC) and regional EOCs in high-risk districts demonstrates a robust preparedness strategy, leveraging experience from previous outbreaks of diseases like mpox and Sudan virus disease to enhance contact tracing and case management. ## A Global Health Alert: What is a PHEIC? The declaration of a Public Health Emergency of International Concern (PHEIC) by the WHO is the highest level of alert under the International Health Regulations (IHR). It signifies an extraordinary event that constitutes a public health risk to other states through the international spread of disease and potentially requires a coordinated international response. This determination by the WHO Director-General, made in consultation with affected countries, underscores the seriousness of the BVD outbreak and its potential for cross-border spread due to factors like high population mobility and porous borders. The PHEIC declaration triggers a set of temporary recommendations for all countries, urging them to enhance surveillance, preparedness, and response measures, while advising against unnecessary restrictions on international travel or trade. ## On the Ground: Response Efforts in DRC Health authorities in the DRC, supported by the WHO and various partners, are implementing extensive public health measures: * **Coordinated Action:** An Incident Management System is actively coordinating the response, supported by technical expertise from WHO. Rapid response teams are deployed to critical health zones. * **Sharpening Surveillance:** Efforts are underway to scale up case investigation, alert management, and contact tracing, though insecurity continues to present major operational hurdles. The International Organization for Migration (IOM) is also assisting with surveillance at points of entry. * **Patient Care and Isolation:** Establishing and operationalizing dedicated isolation and treatment facilities in affected areas is a high priority, alongside ensuring continued access to essential health services. * **Laboratory Power:** The Institut National de la Recherche Biomédicale (INRB) is rapidly expanding laboratory capacity in Bunia and developing a decentralization strategy to set up additional field laboratories closer to affected communities, including near the Uganda border. PCR kits and other critical reagents are being deployed to strengthen testing capabilities. * **Connecting with Communities:** Risk Communication and Community Engagement (RCCE) initiatives, including community mobilization and social listening, are vital to build trust, combat misinformation, and encourage safe health practices. Engagement with local leaders is key. * **Preventing Further Spread:** Infection Prevention and Control (IPC) measures are being strengthened. This includes training over 150 health workers (with plans for 500 more), establishing operational teams for decontamination and safe burials, and donating essential personal protective equipment (PPE) to health facilities. * **Logistical Lifelines:** Over 17 tons of emergency supplies, including PPE, medical equipment, and tents, have been shipped to the DRC. Plans are also underway to mobilize helicopters, ambulances, and armored vehicles to facilitate movement of personnel and cargo in challenging areas. ## Uganda's Preparedness and Response Uganda's Ministry of Health, with support from the WHO and partners, is also implementing robust measures: * **Coordination:** The Incident Management System is activated, and national and regional Emergency Operations Centres (EOCs) are functional, guided by a national response plan. * **Surveillance and Laboratory:** Field teams are using the Go.Data platform for efficient contact tracing, drawing on past experiences. Screening is intensified at borders and transit points, and laboratory systems for sequencing and sample transport are being strengthened, including the deployment of a mobile laboratory near the DRC border. * **Case Management:** Isolation facilities in high-risk districts have been activated, and the Uganda National Emergency Medical Team is supporting clinical management. * **Risk Communication:** Risk communication systems are active, with community messaging and public awareness campaigns delivered through District Health Officer networks. * **Infection Prevention and Control:** Health workers are advised to remain vigilant and strictly adhere to IPC measures. ## Deep-Rooted Challenges and Why This Outbreak is Complex This BVD outbreak is unfolding in an incredibly complex environment. A significant four-week detection gap between the presumed onset of the first case (April 25, 2026) and the laboratory confirmation (May 14, 2026) indicates a low initial suspicion among healthcare providers. This is compounded by the co-circulation of other febrile illnesses, making early diagnosis of BVD even harder and allowing the virus to spread undetected. The tragic deaths of four healthcare workers in a short period underscore critical breaches in IPC protocols, while numerous community deaths suggest unsafe burial practices are contributing to transmission. The ongoing conflict in eastern DRC not only impedes response teams but also drives massive population displacement, creating humanitarian crises and increasing the risk of virus spread across porous borders. The region's role as a commercial and migratory hub further amplifies the risk of regional and international exportation of the virus. ## International Recommendations for Containment The WHO Emergency Committee has issued temporary recommendations for countries globally. For the DRC and Uganda, these include declaring the epidemic a health emergency, activating national emergency mechanisms, and rigorously implementing surveillance, contact tracing, IPC, and risk communication measures. They also emphasize establishing security corridors for responders and ensuring safe and dignified burials. Neighboring countries are urged to enhance readiness, strengthen cross-border surveillance, and provide accurate public information. For all other countries, recommendations focus on detection and management of travelers from affected areas, facilitating evacuation of nationals, and providing public information, while advising against unnecessary travel or trade restrictions. ## The Path Forward Controlling this Bundibugyo Ebola outbreak requires sustained, coordinated efforts at local, national, and international levels. Given the absence of specific vaccines or treatments for BVD, the response relies heavily on robust public health measures: early detection, rapid isolation and supportive care, diligent contact tracing, strict infection prevention and control, and strong community engagement to ensure safe practices and address misinformation. International collaboration, research into medical countermeasures, and unwavering support for the affected nations are paramount to bringing this severe public health emergency under control and protecting lives across the region and beyond.